solifenacin succinate has been researched along with prazosin in 3 studies
| Studies (solifenacin succinate) | Trials (solifenacin succinate) | Recent Studies (post-2010) (solifenacin succinate) | Studies (prazosin) | Trials (prazosin) | Recent Studies (post-2010) (prazosin) |
|---|---|---|---|---|---|
| 522 | 194 | 343 | 7,914 | 713 | 682 |
| Protein | Taxonomy | solifenacin succinate (IC50) | prazosin (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Homo sapiens (human) | 5.87 | |
| Interstitial collagenase | Homo sapiens (human) | 4.036 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.638 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 6.963 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 0.0078 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.29 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.647 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0007 | |
| Bromodomain-containing protein 2 | Homo sapiens (human) | 0.0009 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0006 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.0006 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 4.118 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | 9.9 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.5849 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 1.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kagan, OF; Kheĭfets, VKh; Sosnovskiĭ, SO | 2 |
| Barkin, J; Berner, T; Diles, D; Franks, B | 1 |
1 trial(s) available for solifenacin succinate and prazosin
| Article | Year |
|---|---|
[Peculiarities of clinical course, diagnostics and treatment of overactive bladder in men older than 60 years].
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Prostatitis; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Urological Agents | 2014 |
2 other study(ies) available for solifenacin succinate and prazosin
| Article | Year |
|---|---|
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate | 2015 |
[ASSESSMENT OF EFFICIENCY OF TREATMENT OF OVERACTIVE BLADDER IN ELDERLY PATIENTS].
Topics: Adrenergic alpha-1 Receptor Antagonists; Age Factors; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Prazosin; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2015 |